Regen BioPharma Inc (RGBP)

[art35]

$RGBP today 7/19
- Time for a sit down talk to get reality into perspective. Koos is standing at "The Event Horizon" of this Company that's going to determine its future. This is a "make it or brake it" moment! All Biopharmas reach this point sometime in their development. Most if not ALL of them operate in substantial debt for extended periods typically years, and the only way any of them transition to the BIG TIME is by advancing their IP into clinical trials which we all know requires an enormous amount of capital which they don't have. The capitalization requirements for their IP to transition into clinical trials is way over their heads. The point? Koos needs enormous capital! The good news is he's done everything in his power over the past 18 months to miraculously transform RGBP into a viable B/O candidate, the final step being settling debt, for reason acquiring companies generally have an aversion toward taking on debt. IMO B/O or M/A in progress! This seems to be a foregone conclusion!
OTCShotCaller